Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 309-310, 1999;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berth, M.
Right arrow Articles by De Buyzere, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berth, M.
Right arrow Articles by De Buyzere, M.
Related Collections
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 1999;45:309-310.)
© 1999 American Association for Clinical Chemistry, Inc.


Letters

Reference Values of Serum IgA Subclasses in Caucasian Adults by Immunonephelometry

Mario Berth, Joris Delanghea, Michel Langlois and Marc De Buyzere

Laboratory of Clinical Chemistry, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium
a Author for correspondence. Fax 32 9 240 49 85; e-mail joris.delanghe{at}rug.ac.be.


To the Editor:

Immunoglobulin A (IgA) is a glycoprotein present in plasma (as part of the systemic compartment) and in body secretions (as part of the secretory compartment). Two different subclasses, IgA1 and IgA2, have been described. The IgA1/IgA2 ratio is much higher in the systemic compartment than in the secretory compartment. Serum IgA2 concentrations have been used as an index for mucosal pathology (1)(2). Changes in serum IgA subclass concentrations and changes of the IgA1/IgA2 ratio have been associated with specific diseases and conditions, e.g., subclass deficiency leading to anaphylactic transfusion reactions, chronic alcohol abuse (increased IgA2 concentration and IgA2/IgA1 ratio) (3), and primary IgA nephropathy (increased IgA1 in Caucasians) (4).

Various methods (e.g., immunoradiometry, immunodiffusion, and ELISA) that use subclass-specific antisera (2) or monoclonal antibodies (4)(5)(6) have been proposed for the determination of IgA subclass concentrations in various human body fluids. Recently, subclass-specific antisera have been introduced for application in a nephelometric assay.

The aim of our study was to establish reference values for serum concentrations of the two IgA subclasses in Caucasian adults, using this immunonephelometric assay.

Total IgA and IgA subclasses were assayed using commercial reagents (Hu IgA Subclass BNA Kit; The Binding Site, Birmingham, UK) on a Behring nephelometer (Behringwerke AG). The coefficient of variation, calculated from the results of 10 consecutive determinations of a single sample, was 2.6% for total IgA (at a mean concentration of 1.02 g/L), 4.3% for IgA1 (at a mean concentration of 1.12 g/L), and 3.6% for IgA2 (at a mean concentration of 0.11 g/L). The total serum IgA concentration was standardized against the IFCC/BCR/CAP Reference Material (CRM 470) (7).

The reference subjects were examined by a physician. A questionnaire was used to eliminate recent illnesses, pregnancy, and alcohol (>25 g daily) or drug abuse. Subjects suffering from cardiovascular, endocrine, rheumatic, hematological, infectious, or genito-urinary diseases were excluded from the study. Serum samples were obtained by venipuncture from 276 healthy Belgian individuals. Two samples with a selective IgA2 deficiency were found and were excluded from the study. For determination of reference intervals, we included 274 serum samples from 124 women and 150 men between 18 and 65 years of age.

The serum concentrations, given as the median and interquartile range, of total IgA, IgA1, and IgA2 according to age and gender are shown in Table 1 . The minimum of 120 subjects needed to determine reference values reliably was achieved in the two sex groups, but not in the different individual age groups (8).


View this table:
[in this window]
[in a new window]
 
Table 1. Serum concentrationsa of total IgA, IgA1, and IgA2 according to age and gender.

Serum concentrations of total IgA were higher in men (median, 2.08 g/L; range, 1.49–2.68 g/L) than in women (median, 1.69 g/L; range, 1.24–2.17 g/L; P <0.001), which is in agreement with previous observations (7). This finding was also observed for the serum concentrations of the two IgA subclasses, with men showing significantly higher concentrations than women: for IgA1, 1.80 g/L (1.26–2.35 g/L) for men vs 1.50 g/L (1.03–1.91 g/L) for women (P <0.001); and for IgA2, 0.43 g/L (0.28–0.61 g/L) for men vs 0.33 g/L (0.24–0.47 g/L) for women (P <0.001). The between-gender statistical difference was further evaluated by a standard normal deviate test (z-test): the critical z value (z) was 3.21, and the calculated z values were 3.78 for total IgA, 3.65 for IgA1, and 4.67 for IgA2 (8). The IgA1/IgA2 ratio was not statistically different between genders: 4.44 ± 1.81 for men vs 4.81 ± 1.85 for women; P = 0.07.

The 95% central intervals, which presently are used for interpretive and diagnostic purposes, were 0.72–3.89 g/L for total IgA, 0.61–3.79 g/L for IgA1, and 0.12–1.17 g/L for IgA2 in the male population, and 0.73–3.39 g/L for total IgA, 0.61–3.19 g/L for IgA1, and 0.09–0.69 g/L for IgA2 in the female population.

We found a positive correlation between serum IgA2 and the age of the subjects: y (serum IgA2, mg/L) = 6.71x (age, years) + 151.12; r = 0.340; n = 274; Sy|x = 224.54; P <0.001. Table 1Up shows the data in different age groups. The IgA1/IgA2 ratio was found to be lower in the older population: 4.20 ± 1.59 (>40 years, n = 150) vs 5.10 ± 1.99 (<=40 years, n = 124); P <0.001.

The sum of the IgA subclasses was slightly higher than the total IgA concentration: the (IgA1 + IgA2)/total IgA ratio was 1.09 ± 0.12.

In conclusion, we have established gender-related reference intervals for IgA1 and IgA2 in serum from human adults, using immunonephelometry. When evaluating IgA1 and IgA2 serum concentrations, one should take into account the patient's age and gender for correct interpretation.


Acknowledgments

We thank The Binding Site (Birmingham, UK) for providing the reagents to perform this study.


References

  1. Mestecky J, Russell MW, Jackson S, Brown TA. The human IgA system: a reassessment. Clin Immunol Immunopathol 1986;40:105-114. [ISI][Medline] [Order article via Infotrieve]
  2. Delacroix DL, Dive C, Rambaud JC, Vaerman JP. IgA subclasses in various secretions and in serum. Immunology 1982;47:383-385. [Medline] [Order article via Infotrieve]
  3. Meillet D, Labrousse F, Benoit MO, Hernvann A, Musset L, van Amerongen G. Increased serum concentration of IgA2 subclass and IgA2/IgA1 ratio: specific markers of chronic alcoholic abuse?. Eur J Clin Chem Clin Biochem 1997;35:275-279. [Medline] [Order article via Infotrieve]
  4. Van den Wall Bake AW, Daha MR, Van der Ark A, Hiemstra PS, Radl L, Van Es LA. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol 1988;74:115-120. [Medline] [Order article via Infotrieve]
  5. Depelchin S, Dehennin JP, Bottaro A, Carbonara A, Vaerman JP, Sibille Y. Validation of IgA1 and IgA2 measurements by a solid-phase immunoradiometric assay in serum and secretions. Int J Clin Lab Res 1994;24:154-161. [Medline] [Order article via Infotrieve]
  6. Mestecky J, Hamilton RG, Magnusson CG, Jefferis R, Vaerman JP, Goodall M, et al. Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study. J Immunol Methods 1996;193:103-148. [Medline] [Order article via Infotrieve]
  7. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). Eur J Clin Chem Clin Biochem 1996;34:517-520. [ISI][Medline] [Order article via Infotrieve]
  8. Sasse EA, Aziz KJ, Harris EK, Krishnamurthy S, Lee HT, Ruland A, Seamonds B. How to define and determine reference intervals in the clinical laboratory; approved guideline. NCCLS Document C28-A. Villanova, PA: NCCLS, 1995:4..




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berth, M.
Right arrow Articles by De Buyzere, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berth, M.
Right arrow Articles by De Buyzere, M.
Related Collections
Right arrow Drug Monitoring and Toxicology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS